Figure S2 from Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium

Abstract

Correlation between Ras pathway mutation VAF and in vitro sensitivity to MEK inhibitors.